# Single-Dose Safety Study of APD791 in Healthy Volunteers

> **NCT00529646** · PHASE1 · COMPLETED · sponsor: **Arena Pharmaceuticals** · enrollment: 90 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** APD791

## Key facts

- **NCT ID:** NCT00529646
- **Lead sponsor:** Arena Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2008-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00529646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00529646, "Single-Dose Safety Study of APD791 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00529646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*